SCHEMBL5113092

SCHEMBL5113092

CCOC(=O)CCc1ccc(N)cc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.47
CYP4A11 Q02928 3/20 0.47
EPHX2 P34913 1/20 0.46
NR1H2 P55055 1/20 0.42
DPP4 P27487 1/20 0.41
GAA P10253 2/20 0.40
ALDH1A1 P00352 1/20 0.40
PPIB P23284 1/20 0.39
PPIA P62937 1/20 0.39
PPID Q08752 1/20 0.39
PPIG Q13427 1/20 0.39
TNF P01375 4/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.39
BRCA1 P38398 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12676663 0.86 NR1H2 (0.44) NR1H2GAAALDH1A1PPIBPPIA
SCHEMBL1016308 0.86 NR1H2 (0.47) EPHX2NR1H2GAAALDH1A1GLA
SCHEMBL5990285 0.85 CYP4F2 (0.48) CYP4F2CYP4A11EPHX2DPP4GAA
SCHEMBL15936212 0.85 CYP4F2 (0.48) CYP4F2CYP4A11EPHX2GAAALDH1A1
SCHEMBL23465487 0.84 NR1H2 (0.42) EPHX2NR1H2GAAGLAPOLB
SCHEMBL3502904 0.82 CYP4F2 (0.50) CYP4F2CYP4A11GAAALDH1A1PPIB
SCHEMBL28851037 0.82 CYP4F2 (0.45) CYP4F2CYP4A11EPHX2DPP4GAA
SCHEMBL3631411 0.81 CYP4F2 (0.53) CYP4F2CYP4A11GAAALDH1A1PPIB
SCHEMBL2130827 0.81 CYP4F2 (0.53) CYP4F2CYP4A11GAAALDH1A1PPIB
SCHEMBL4081569 0.80 EPHX2 (0.65) CYP4F2CYP4A11EPHX2GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609656-B2 Heteroarylphenylurea derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-12-17 US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 US disclosed
EP-1724258-A1 HETEROARYLPHENYLUREA DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119466-A1 Heteroarylphenylurea Derivative CHRM1, CBR3, CHRM2 CYP4F2 105/4885CYP4A11 5/4885EPHX2 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.